Abouzaid, Safiya <br/><br/>
Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia.  [electronic resource] 

 -  Population health management  Oct 2010 
 - 247-54 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1942-7905 
<br/><br/><label>Standard No.: </label>10.1089/pop.2009.0063  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antidepressive Agents, Second-Generation--economics<br/>Cost Savings<br/>Decision Trees<br/>Health Care Costs<br/>Humans<br/>Insurance Claim Review--economics<br/>Insurance, Pharmaceutical Services--economics<br/>Medicaid--economics<br/>Monte Carlo Method<br/>Organizational Policy<br/>Probability<br/>Schizophrenia--drug therapy<br/>United States